R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells
about
Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migrationA Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent CancersDickkopfs and Wnt/β-catenin signalling in liver cancerNovel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsDrug development against metastasis-related genes and their pathways: A rationale for cancer therapyIdentification and characterization of a novel small-molecule inhibitor of β-catenin signalingSynthesis of Ni(II) complexes bearing indole-based thiosemicarbazone ligands for interaction with biomolecules and some biological applications.Crystal and molecular structure of beta-cyclodextrins functionalized with the anti-inflammatory drug Etodolac.MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.Role of Wnt/β-catenin signaling in liver metabolism and cancerMicroRNA roles in beta-catenin pathway.Expression level of glutamine synthetase is increased in hepatocellular carcinoma and liver tissue with cirrhosis and chronic hepatitis B.Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis modelThe Wnt/β-catenin signaling pathway in liver biology and disease.siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survivalγ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown.Wnt/beta-catenin signaling in hepatic organogenesis.Unique phenotype of hepatocellular cancers with exon-3 mutations in beta-catenin gene.FHIT overexpression in HepG2 hepatoma cells affects growth and cyclin D1 expression in vitro.Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver.Anti-cancer and anti-hepatitis C virus NS5B polymerase activity of etodolac 1,2,4-triazoles.Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts.Pharmacological inhibition of beta-catenin in hepatoblastoma cells.Pegylated interferon alpha targets Wnt signaling by inducing nuclear export of β-catenin.The inhibitory effect of celecoxib on mouse hepatoma H22 cell line on the arachidonic acid metabolic pathway.Pathological implications of cadherin zonation in mouse liver.Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.
P2860
Q24297486-09B2DB04-F03C-4059-B8C6-8478223E3C90Q26739665-602C6403-E2C4-4FA6-8773-0831502FF075Q28391394-881656E9-E354-416B-9BD7-E8787FA9034BQ28546685-0C6B7DBB-C261-4C3E-A1CF-0DEB7A1B089AQ29010479-C6BBCC61-02E0-4F60-A5E0-3C76FA05CC36Q30384345-98579AE1-A4CD-43B8-88A6-7DA9C8C04D43Q32183819-AC794B26-09C8-4A96-B362-E0A3A73E4325Q33430067-0DA4E1A4-EAFD-4032-97B9-B37BC0B6762FQ33888977-C20C3461-55CD-496A-A2FD-5494CE52B168Q33940403-961A1114-4D56-433A-B843-59784CB2640FQ34202840-19F1AC2F-1EAA-4E27-80E7-9E6E2AEBD7EFQ34959601-0DE5D9F7-C852-4FE1-814C-629BA54E9FD1Q34989670-A1602926-E731-4E75-9DFB-EE1EEC78AA57Q35819799-FC57204A-36CA-4110-B7B7-63C42DA61790Q36143616-02603067-8420-4A03-A4A3-C2EB7E75C894Q36730590-2B7CAF6D-613C-41DE-ABEA-37816B093E21Q37080175-9E5247FD-4965-412B-A591-2A9F914C7FDBQ37132646-2139B91E-2CA4-4342-9CE2-CE8EED54CF02Q37434450-E274E11B-78A9-4AC0-BCF4-4FBD70CB7435Q37459941-96338B3E-15CD-49A9-A2C8-F8AEA0B35647Q38910335-2F28F77B-6D8F-408C-B7B4-77E4F69026D9Q38970692-F49F6454-7257-488E-941A-E73A05E6D9CFQ39220952-12D1CC6D-CFFE-4132-9D9F-2F3BEF89F610Q39629533-AE64B265-8229-4494-B224-CD151DA185D6Q39677057-209C8B8F-CBD1-4E7A-8494-2B28E18D93E9Q52657449-C1143E2D-2137-4BBF-8971-BE510BFDD526Q55400399-C4E4FDC3-7538-48B0-8FC4-ADE5647CA9AC
P2860
R-Etodolac decreases beta-catenin levels along with survival and proliferation of hepatoma cells
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@ast
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@en
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@nl
type
label
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@ast
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@en
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@nl
prefLabel
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@ast
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@en
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@nl
P2093
P2860
P3181
P1476
R-Etodolac decreases beta-cate ...... roliferation of hepatoma cells
@en
P2093
Amanda Micsenyi
Jaideep Behari
Lorenzo Leoni
Michael D Thompson
Peggy Muller
Sandeep S Sekhon
Satdarshan P S Monga
Wade Otruba
P2860
P304
P3181
P356
10.1016/J.JHEP.2006.11.017
P407
P577
2007-05-01T00:00:00Z